(Q71029630)
Statements
HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor (English)
Elsässer D
Valerius T
Repp R
Weiner GJ
Deo Y
Kalden JR
van de Winkel JG
Stevenson GT
Glennie MJ